Foundations of Combination Products in the EU
This presentation will briefly cover the role of notified bodies in Europe and how they fit into the conformity assessment process for combination products. It will focus on integral drug device combinations and the requirements for a Notified Body Opinion (NBOp), including feedback on submissions and common pitfalls to aid better dossier preparation.